This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1076029607310217v1 15/3/340    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Larrañaga, G. d. Articles by Benetucci, J. Search for Related Content PubMed PubMed Citation Articles by Larrañaga, G. d. Articles by Benetucci, J. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Osteonecrosis Social Bookmarking                         What's this?

Thrombophilia in Human Immunodeficiency Virus–Infected Patients With Osteonecrosis: Is There a Real Connection? The First Case-Control Study

^* To whom correspondence should be addressed. E-mail: gabriela{at}hemostasia.com.ar.

	Abstract

Several reports have described an increased incidence of osteonecrosis in human immunodeficiency virus–infected patients (HIV+), but the cause has not been established. The association between thrombophilia and osteonecrosis in HIV+ was studied. A case-control study in HIV+, 19 cases and 38 controls, was designed. Magnetic resonance imaging was made in both groups to confirm or exclude hip osteonecrosis. The extensive tests of thrombophilia were measured, and the clinical data were recorded, nadir of CD4⁺ cell count and well-known risk factors for osteonecrosis. Thrombophilia has been frequently found both in patients with and without osteonecrosis (thrombophilia, 68.4% vs 60.5%), but no specific thrombophilia tests were significantly associated with osteonecrosis. A low nadir of CD4⁺(<60 cells/µL) and corticoid use were significantly (P < .05) associated with osteonecrosis. In multivariate analysis, only nadir of CD4⁺ <60 cells/µL remained a predictor of osteonecrosis (odds ratio = 7.33; 95% confidence interval, 1.8029.82, P = .005). Thrombophilia might have a limited role in the development of osteonecrosis in HIV+. Nadir of CD4⁺ <60 cells/µL and corticoid use were main factors.

First published on December 26, 2007, doi:10.1177/1076029607310217

Clinical and Applied Thrombosis/Hemostasis 2009;15:340.

A more recent version of this article appeared on June 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?